Physician profile
Mark D Rahm
NPI 1194786418
$9,912.68
in general payments reported to CMS, 2019-2025
10 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,544 · 2020: $310 · 2022: $1,342 · 2023: $1,189 · 2024: $309 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1,189 · Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,188.50 |
| Food and Beverage | $528.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinesmith Holdings, LLC | $8,770.92 | 2019-2023 | |
| Camber Spine Technologies LLC | $309.66 | 2020 | |
| Stryker Corporation | $308.98 | 2024 | Cascadia Interbody System, Ozark Cervical Plate System, Everest Spinal System |
| Nuvasive, INC. | $194.23 | 2019 | |
| Si-Bone, INC. | $149.92 | 2025 | |
| Medtronic USA, INC. | $109.52 | 2019 | |
| Dilon Technologies, INC. | $24.44 | 2025 | Hemoblast Bellows |
| Medtronic, INC. | $23.18 | 2025 | Anteralign Spinal System With Titan Nanolock Surface Technology |
| Smith+Nephew, INC. | $21.83 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rahm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.